Evaluation of Infliximab and Anti-infliximab LISA-TRACKER Immunoassays for the Therapeutic Drug Monitoring of SB2 Infliximab Biosimilar. [electronic resource]
- Therapeutic drug monitoring 12 2018
- 749-753 p. digital
Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
1536-3694
10.1097/FTD.0000000000000565 doi
Biosimilar Pharmaceuticals--blood Drug Monitoring--methods Humans Immunoassay Infliximab--blood